Dupilumab

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5360 publications

Dupilumab treatment of linear IgA bullous dermatosis in a child.

Dupilumab treatment of linear IgA bullous dermatosis in a child.

Journal: European journal of dermatology : EJD

Published: September 06, 2026

Evaluating the effect of age and comorbidity on dupilumab-dependent immunoglobulin E reduction in children with food allergy.

Evaluating the effect of age and comorbidity on dupilumab-dependent immunoglobulin E reduction in children with food allergy.

Journal: Allergy and asthma proceedings

Published: September 05, 2026

Pharmacovigilance signals of dupilumab among pediatric patients: A real‑world analysis based on the FAERS database.

Pharmacovigilance signals of dupilumab among pediatric patients: A real‑world analysis based on the FAERS database.

Journal: Human vaccines & immunotherapeutics

Published: September 04, 2026

Comment on "Real-world outcomes after biologic-to-biologic switching to dupilumab in adult asthma: A retrospective single-center cohort study".

Comment on "Real-world outcomes after biologic-to-biologic switching to dupilumab in adult asthma: A retrospective single-center cohort study".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: September 03, 2026

Dupilumab-Associated Mycosis Fungoides: Unmasked, Direct Effect, or a Lymphoid Reaction?

Dupilumab-Associated Mycosis Fungoides: Unmasked, Direct Effect, or a Lymphoid Reaction?

Journal: The American Journal of dermatopathology

Published: September 02, 2026

Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults.

Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults.

Journal: JAMA dermatology

Published: September 02, 2026

Impact and management of biologic therapies on small airway dysfunction in severe asthma: a comprehensive review.

Impact and management of biologic therapies on small airway dysfunction in severe asthma: a comprehensive review.

Journal: Expert review of respiratory medicine

Published: August 31, 2026

IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.

IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 28, 2026

Repositioning omalizumab in dermatology: emerging indications and mechanism-based therapeutic insights.

Repositioning omalizumab in dermatology: emerging indications and mechanism-based therapeutic insights.

Journal: Expert opinion on biological therapy

Published: August 28, 2026

Dupilumab versus omalizumab in chronic rhinosinusitis with nasal polyps and asthma: a plain language summary.

Dupilumab versus omalizumab in chronic rhinosinusitis with nasal polyps and asthma: a plain language summary.

Journal: Expert opinion on biological therapy

Published: August 26, 2026

Relentless Placoid Chorioretinitis in a Patient with Atopic Dermatitis Treated with Dupilumab.

Relentless Placoid Chorioretinitis in a Patient with Atopic Dermatitis Treated with Dupilumab.

Journal: Ocular immunology and inflammation

Published: August 25, 2026

Dupilumab treatment improves signs, symptoms, and quality of life in children aged 6 months to 11 years with moderate-to-severe atopic dermatitis: a plain language summary.

Dupilumab treatment improves signs, symptoms, and quality of life in children aged 6 months to 11 years with moderate-to-severe atopic dermatitis: a plain language summary.

Journal: The Journal of dermatological treatment

Published: August 24, 2026

Showing 1-12 of 5,360

Last Updated: 09/26/2026